Who owns BIOTECHNOLOGY VALUE FUND II LP?

No ownership or control links for BIOTECHNOLOGY VALUE FUND II LP are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is BIOTECHNOLOGY VALUE FUND II LP's risk level?

WhiteIntel flags BIOTECHNOLOGY VALUE FUND II LP as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does BIOTECHNOLOGY VALUE FUND II LP appear across sources?

BIOTECHNOLOGY VALUE FUND II LP is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

●

BIOTECHNOLOGY VALUE FUND II LP

Name: BIOTECHNOLOGY VALUE FUND II LP — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, BIOTECHNOLOGY VALUE FUND II LP, Person, US

Low

PersonUS

View network JSON / MCPsample

SnitchScore · reading…

placeholder

The finding

Controls or directs 103 companies in the resolved graph.

/01

Key facts

Risk signal

Controls: 103 companies
Risk: Low
Jurisdiction: US

Low

Risk

BIOTECHNOLOGY VALUE FUND II LP controls or directs 103 companies (US).

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

BIOTECHNOLOGY VALUE FUND II LP
- XOMA Royalty Corp· 10% owner· via SEC EDGAR (Form 3/4/5)
- Olema Pharmaceuticals, Inc.· director· via SEC EDGAR (Form 3/4/5)
- AEOLUS PHARMACEUTICALS, INC.· tenpercentowner· via SEC EDGAR
- ADVANCED MAGNETICS INC· other· via SEC EDGAR
- MoonLake Immunotherapeutics· other· via SEC EDGAR
- Kymera Therapeutics, Inc.· director· via SEC EDGAR
- IMMUNIC, INC.· director· via SEC EDGAR
- Repare Therapeutics Inc.· other· via SEC EDGAR
- ESSA PHARMA INC.· other· via SEC EDGAR
- Allakos Inc.· other· via SEC EDGAR
- CRESCENT BIOPHARMA, INC.· other· via SEC EDGAR
- Third Harmonic Bio, Inc.· other· via SEC EDGAR
- 4D Molecular Therapeutics, Inc.· other· via SEC EDGAR
- PALVELLA THERAPEUTICS, INC.· other· via SEC EDGAR
- Eledon Pharmaceuticals, Inc.· other· via SEC EDGAR
- RAIN ONCOLOGY INC.· director· via SEC EDGAR
- POINT BIOPHARMA GLOBAL INC.· other· via SEC EDGAR
- enGene Holdings Inc.· other· via SEC EDGAR
- CELL THERAPEUTICS INC· other· via SEC EDGAR
- Structure Therapeutics Inc.· other· via SEC EDGAR
- Cullinan Therapeutics, Inc.· other· via SEC EDGAR
- Verastem, Inc.· other· via SEC EDGAR
- Merus N.V.· other· via SEC EDGAR
- FIVE PRIME THERAPEUTICS INC· other· via SEC EDGAR
- CytomX Therapeutics, Inc.· other· via SEC EDGAR
- IDEAYA Biosciences, Inc.· other· via SEC EDGAR
- DISCOVERY PARTNERS INTERNATIONAL INC· other· via SEC EDGAR
- CYTOKINETICS INC· other· via SEC EDGAR
- PRINCIPIA BIOPHARMA INC.· other· via SEC EDGAR
- CALITHERA BIOSCIENCES, INC.· other· via SEC EDGAR
- CONCERT PHARMACEUTICALS INC· other· via SEC EDGAR
- IMMUNE DESIGN CORP.· other· via SEC EDGAR
- Syndax Pharmaceuticals Inc· other· via SEC EDGAR
- ARQULE INC· other· via SEC EDGAR
- Xenon Pharmaceuticals Inc.· other· via SEC EDGAR
- Regulus Therapeutics Inc.· other· via SEC EDGAR
- CAPSTONE HOLDING CORP.· other· via SEC EDGAR
- ALPINE IMMUNE SCIENCES, INC.· other· via SEC EDGAR
- BIOMIRA CORP· tenpercentowner· via SEC EDGAR
- CHEMOCENTRYX, INC.· other· via SEC EDGAR
- GYRE THERAPEUTICS, INC.· other· via SEC EDGAR
- ARRAY BIOPHARMA INC· other· via SEC EDGAR
- INTERFILM INC· other· via SEC EDGAR
- REGADO BIOSCIENCES INC· other· via SEC EDGAR
- LIGAND PHARMACEUTICALS INC· other· via SEC EDGAR
- RIGEL PHARMACEUTICALS INC· other· via SEC EDGAR
- NEUROCRINE BIOSCIENCES INC· other· via SEC EDGAR
- CORTECH INC· other· via SEC EDGAR
- ICAGEN INC· other· via SEC EDGAR
- CELERA CORP· other· via SEC EDGAR
- ASTEX PHARMACEUTICALS, INC· other· via SEC EDGAR
- ABBOTT BIOTHERAPEUTICS CORP· other· via SEC EDGAR
- MEDICINOVA INC· tenpercentowner· via SEC EDGAR
- NEUROBIOLOGICAL TECHNOLOGIES INC /CA/· other· via SEC EDGAR
- AVIGEN INC \DE· other· via SEC EDGAR
- COMBINATORX INC· other· via SEC EDGAR
- REPLIGEN CORP· other· via SEC EDGAR
- DYNAVAX TECHNOLOGIES CORP· other· via SEC EDGAR
- ADOLOR CORP· other· via SEC EDGAR
- CURIS INC· other· via SEC EDGAR
- INHIBITEX INC· tenpercentownerother· via SEC EDGAR
- PHARMACOPEIA DRUG DISCOVERY INC· tenpercentownerother· via SEC EDGAR
- NPS PHARMACEUTICALS INC· other· via SEC EDGAR
- SGX PHARMACEUTICALS, INC.· other· via SEC EDGAR
- VIACELL INC· other· via SEC EDGAR

/03

Directorship network

983 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

XOMA Royalty Corp

Sitko Bradleyofficer
BIOTECHNOLOGY VALUE FUND L P10% owner
BVF II GP LLC10% owner
BVF PARTNERS L P/IL10% owner
BVF INC/IL10% owner
BVF GP HOLDINGS LLC10% owner
BVF I GP LLC10% owner
LAMPERT MARK N10% owner
BVF Partners OS Ltd.director
Biotechnology Value Trading Fund OS LPdirector
Sitko Bradleyofficer
Sitko Bradleyofficer
SCANNON PATRICK J MD PHDofficer
CASTELLO JOHN Ldirector
CASTELLO JOHN Lofficer
SCANNON PATRICK J MD PHDdirector
MARGOLIN CHRISTOPHER Jofficer
BOYLE J DAVID IIofficer
MONTANO MARICEL PEREAofficer
BIOTECHNOLOGY VALUE FUND L Ptenpercentowner
PERRY MATTHEW Ddirector
KOSACZ BARBARAdirector
LIMBER JOSEPH Mdirector
BVF GP HOLDINGS LLCtenpercentowner
BVF INC/ILtenpercentowner
LAMPERT MARK Ntenpercentowner
BVF I GP LLCtenpercentowner
HUGHES OWENofficer
Biotechnology Value Trading Fund OS LPother
FRANKLIN HEATHER Ldirector
BVF II GP LLCtenpercentowner
TRIGILIO JEFFREYofficer
WYSZOMIERSKI JACK Ldirector
BVF PARTNERS L P/ILtenpercentowner
HUGHES OWENdirector
BVF Partners OS Ltd.other
Sitko Bradleyofficer
HERNDAY NATASHAdirector

Olema Pharmaceuticals, Inc.

Myles David C.officer
Zojwalla Naseemofficer
Mitchell Shawnteofficer
Kovacs Shane William Charlesofficer
Bohen Seanofficer
Mitchell Shawnteofficer
BVF Partners OS Ltd.director
Biotechnology Value Trading Fund OS LPdirector
LAMPERT MARK Ndirector
BVF PARTNERS L P/ILdirector
BIOTECHNOLOGY VALUE FUND L Pdirector
BVF GP HOLDINGS LLCdirector
BVF I GP LLCdirector
BVF II GP LLCdirector
BVF INC/ILdirector
Bain Capital Life Sciences Investors, LLC10% owner
Bain Capital Life Sciences Opportunities IV, L.P.10% owner
Bain Capital Life Sciences Fund IV, L.P.10% owner
Bain Capital Life Sciences Opportunities IV GP, LLC10% owner
Bain Capital Life Sciences IV General Partner, LLC10% owner
Bain Capital Life Sciences Investors, LLC10% owner
Bain Capital Life Sciences Opportunities IV GP, LLC10% owner
Bain Capital Life Sciences Opportunities IV, L.P.10% owner
Bain Capital Life Sciences Fund IV, L.P.10% owner
Bain Capital Life Sciences IV General Partner, LLC10% owner
LARSON YIdirector
BVF GP HOLDINGS LLCdirector
Garland J. Scottdirector
Biotechnology Value Trading Fund OS LPdirector
LAMPERT MARK Nother
HRUSTANOVIC GORJANdirector
CLARK IAN Tdirector
BVF PARTNERS L P/ILother
Raman Prakashdirector
HARMON CYRUSdirector
BVF I GP LLCdirector
Graham G. Walmsleydirector
RAPPAPORT ANDREWdirector
BVF INC/ILother
BVF II GP LLCdirector
BVF Partners OS Ltd.other
BVF GP HOLDINGS LLCother
BVF II GP LLCother
BIOTECHNOLOGY VALUE FUND L Pdirector
Biotechnology Value Trading Fund OS LPother
BVF Partners OS Ltd.director
BVF PARTNERS L P/ILdirector
BVF I GP LLCother
BIOTECHNOLOGY VALUE FUND L Pother
BVF INC/ILdirector
BUTITTA CYNTHIA Mdirector
HORNING SANDRAdirector
LAMPERT MARK Ndirector
Bohen Seandirector
Myles David C.officer
AUSTIN SASHA LUofficer

AEOLUS PHARMACEUTICALS, INC.

BVF INVESTMENTS LLCtenpercentowner
XMARK OPPORTUNITY PARTNERS, LLCtenpercentowner
BIOTECHNOLOGY VALUE FUND L Ptenpercentowner
MAMANUS MICHAEL Pofficer
BVF PARTNERS L P/ILtenpercentownerother
ALEXANDER ELAINEofficer
FARAH JOHN M JRdirector
BVF INC/ILtenpercentownerother
MCMANUS JOHN Lofficer

ADVANCED MAGNETICS INC

MoonLake Immunotherapeutics

Santos da Silva Jorgeofficer
Reich Kristianofficer
Bodenstedt Matthiasofficer
Reich Kristianofficer
BIOTECHNOLOGY VALUE FUND L Pdirector
LAMPERT MARK Ntenpercentowner
BVF II GP LLCdirector
BVF PARTNERS L P/ILtenpercentowner
XAVIER RAMNIKdirector
BVF I GP LLCtenpercentowner
Bodenstedt Matthiasofficer
BVF GP HOLDINGS LLCtenpercentowner
Biotechnology Value Trading Fund OS LPother
BVF Partners OS Ltd.director
BVF Partners OS Ltd.other
Santos da Silva Jorgedirector
BVF II GP LLCtenpercentowner
Reich Kristianofficer
Biotechnology Value Trading Fund OS LPdirector
LAMPERT MARK Ndirector
Phillips Andrew Johndirector
LOY SPIKEdirector
BVF INC/ILtenpercentowner
Santos da Silva Jorgeofficer
MOUKHEIBIR CATHERINEdirector
BVF II GP LLCother
BVF GP HOLDINGS LLCdirector
BVF PARTNERS L P/ILdirector
BVF INC/ILdirector
BIOTECHNOLOGY VALUE FUND L Ptenpercentowner
BVF I GP LLCdirector

Kymera Therapeutics, Inc.

Chiniara Ellenofficer
Chadwick Jeremy Gofficer
Jacobs Bruce N.officer
Mainolfi Nelloofficer
Gollob Jaredofficer
Mainolfi Nelloofficer
Jacobs Bruce N.officer
Chiniara Ellenofficer
BVF II GP LLCother
BIOTECHNOLOGY VALUE FUND L Pother
BVF I GP LLCdirector
BVF II GP LLCdirector
LAMPERT MARK Ndirector
Baker Brothers Life Sciences LPdirector
LAMPERT MARK Nother
Booth Brucedirector
SANDOR VICTORdirector
BIOTECHNOLOGY VALUE FUND L Pdirector
667, L.P.tenpercentowner
HRUSTANOVIC GORJANdirector
ESPOSITO PAMELAdirector
BVF INC/ILdirector
667, L.P.director
Mainolfi Nelloofficer
Albers Jeffrey W.director
BVF I GP LLCother
Ridloff Elenadirector
Chadwick Jeremy Gofficer
Baker Brothers Life Sciences LPtenpercentowner
Biotechnology Value Trading Fund OS LPother
BAKER FELIXtenpercentowner
BAKER BROS. ADVISORS LPdirector
BVF PARTNERS L P/ILdirector
BVF Partners OS Ltd.director
MARAGANORE JOHNdirector
BVF GP HOLDINGS LLCdirector
BVF INC/ILother
GOODMAN NOAHofficer
Biotechnology Value Trading Fund OS LPdirector
Baker Bros. Advisors (GP) LLCdirector
BAKER BROS. ADVISORS LPtenpercentowner
Mainolfi Nellodirector
Jacobs Bruce N.officer
BAKER JULIANdirector
Baker Bros. Advisors (GP) LLCtenpercentowner
BVF PARTNERS L P/ILother
BVF GP HOLDINGS LLCother
BAKER FELIXdirector
BVF Partners OS Ltd.other
BAKER JULIANtenpercentowner
Gollob Jaredofficer

IMMUNIC, INC.

Repare Therapeutics Inc.

Koehler Mariaofficer
Zinda Michaelofficer
Forte Steveofficer
Segal Lloyd Mitchellofficer
Segal Lloyd Mitchellofficer
Zinda Michaelofficer
Forte Steveofficer
BVF I GP LLCtenpercentowner
CIVIK THOMASdirector
LAMPERT MARK Ntenpercentowner
BVF INC/ILtenpercentowner

Allakos Inc.

CRESCENT BIOPHARMA, INC.

Balcom Alexandradirector
FAIRMOUNT FUNDS MANAGEMENT LLCtenpercentowner
HARWIN PETER EVANtenpercentowner
FAIRMOUNT FUNDS MANAGEMENT LLCdirector
KISELAK TOMASdirector
BISPHAM BARBARA HARLINofficer
MCNEILL JONATHANofficer
IM ELLIE EUNKYUNGofficer
Scalzo Richard Williamofficer
KISELAK TOMAStenpercentowner
FAIRMOUNT HEALTHCARE FUND II L.P.tenpercentowner
FAIRMOUNT HEALTHCARE FUND II L.P.director
BRUMM JOSHUA Tdirector
PINKAS JANofficer
LUBNER DAVID CHARLESdirector
HARWIN PETER EVANdirector
LYNCH RYANofficer
MORAN SUSANdirector
VIOLIN JONATHANdirector
BRUMM JOSHUA Tofficer

Third Harmonic Bio, Inc.

4D Molecular Therapeutics, Inc.

PALVELLA THERAPEUTICS, INC.

Eledon Pharmaceuticals, Inc.

enGene Holdings Inc.

CELL THERAPEUTICS INC

Structure Therapeutics Inc.

Coll Crespo Blasofficer
Hall Ashleyofficer
Ma Yingliofficer
Lin Xichenofficer
Yoon Junofficer
Stevens Raymond Cofficer
FMR LLC10% owner
Russell Angus C.director
DOBMEIER ERICdirector
TETLOW SHARONdirector
LOVE TED Wdirector
Lin Xichenofficer
FMR LLCother
Waldstreicher Joannedirector
Lang Matthewofficer
FMR LLCtenpercentowner
WELCH DANIEL Gdirector
Coll Crespo Blasofficer

Cullinan Therapeutics, Inc.

Verastem, Inc.

Merus N.V.

CytomX Therapeutics, Inc.

IDEAYA Biosciences, Inc.

DISCOVERY PARTNERS INTERNATIONAL INC

HIXSON HARRY F JRdirector
PIGLIUCCI RICCARDOother

CYTOKINETICS INC

Syndax Pharmaceuticals Inc

ARQULE INC

Xenon Pharmaceuticals Inc.

Regulus Therapeutics Inc.

CAPSTONE HOLDING CORP.

GYRE THERAPEUTICS, INC.

Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ye Weiguoofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Ma Songjiangofficer
Zhang Pingdirector
Zhang Pingdirector
Ma Songjiangofficer
Ma Songjiangofficer
WENG DANdirector
EPSTEIN DAVID M.director
Zhang Pingdirector
Ye Weiguoofficer
XIONG YUEofficer
GNI USA, INC.tenpercentowner
GNI GROUP LTD.tenpercentowner
NUSSBAUM RODNEY Ldirector
EASTLING THOMAS WILSONofficer
PARRY RENATEdirector
LUO YINGofficer
CARMICHAEL GORDONdirector
LUO YINGdirector
WANG JIALIANG (NMN)officer
BERGMANN JOSHUA BENJAMINofficer

ARRAY BIOPHARMA INC

LIGAND PHARMACEUTICALS INC

RIGEL PHARMACEUTICALS INC

NEUROCRINE BIOSCIENCES INC

CORTECH INC

ASSET VALUE FUND LIMITED PARTNERSHIPtenpercentowner

ICAGEN INC

WAGONER KAYofficer
KATZ RICHARD Dofficer
WAGONER KAYtenpercentowner
SANDERS CHARLES Adirector
WAGONER KAYdirector
HULL HEYWARDofficer
GRAY EDWARD Pofficer

ASTEX PHARMACEUTICALS, INC

MEDICINOVA INC

NEUROBIOLOGICAL TECHNOLOGIES INC /CA/

AVIGEN INC \DE

COMBINATORX INC

REPLIGEN CORP

DYNAVAX TECHNOLOGIES CORP

Novack David Fofficer
Novack David Fofficer
Novack David Fofficer
Slebir John Lofficer
Janssen Robertofficer
MacDonald Kellyofficer
Spencer Ryanofficer
Novack David Fofficer
Spencer Ryanofficer
Slebir John Lofficer
Novack David Fofficer
MacDonald Kellyofficer
Janssen Robertofficer
Novack David Fofficer
Slebir John Lofficer
Spencer Ryanofficer
MacDonald Kellyofficer
Janssen Robertofficer
Burgess Justinofficer
SILVERNAIL LAUREN Pdirector
SILVERNAIL LAUREN Pdirector
Emini Emiliodirector
Emini Emiliodirector
DEERFIELD INTERNATIONAL LTDtenpercentownerother
DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTDtenpercentownerother
DEERFIELD PARTNERS, L.P.tenpercentownerother
DINA DINOdirector
DEERFIELD SPECIAL SITUATIONS FUND, L.P.tenpercentownerother
COFFMAN ROBERTofficer
VAN NEST GARY Aofficer
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)tenpercentownerother
TUCK STEPHEN Fofficer
CARSON DENNISdirector
Flynn James Etenpercentowner
ORONSKY ARNOLD Ldirector
SMELTZER DEBORAH Aofficer
LEVITT DANIEL Jofficer
HENN TIMOTHY Gofficer
DINA DINOofficer
DEERFIELD CAPITAL LPtenpercentownerother
MACGREGOR BRENTdirector
KROIN DAVIDtenpercentowner
SILVERNAIL LAUREN Pdirector

ADOLOR CORP

CURIS INC

INHIBITEX INC

PHARMACOPEIA DRUG DISCOVERY INC

NPS PHARMACEUTICALS INC

SGX PHARMACEUTICALS, INC.

ATLAS VENTURE ASSOCIATES III L Ptenpercentowner
ATLAS VENTURE FUND IV, L.P.tenpercentowner
PAPADOPOULOS STELIOSdirector
MYERS W TODDofficer
ATLAS VENTURE ENTREPRENEURS FUND IV, L.P.tenpercentowner
BOCK LOUIS Cdirector
ATLAS VENTURE ASSOCIATES IV, L.P.tenpercentowner
GREY MICHAEL Gdirector
CREDIT SUISSE AG/tenpercentowner
FORMELA JEAN FRANCOISdirector
EASTHAM KARINdirector
FORMELA JEAN FRANCOIStenpercentowner
NORTH ANNETTEofficer
BOCK LOUIS Ctenpercentowner
ATLAS VENTURE FUND III L Ptenpercentowner
GREY MICHAEL Gofficer
ATLAS VENTURE PARALLEL FUND IV-A, C.V.tenpercentowner
BAVP, L.P.tenpercentowner
LATHI VIJAY Kdirector
ATLAS VENTURE ENTREPRENEURS FUND III L Ptenpercentowner
HENNEY CHRISTOPHER Sdirector
REICH SIEGFRIEDofficer
BURLEY STEPHENofficer
LATHI VIJAY Ktenpercentowner

VIACELL INC

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on BIOTECHNOLOGY VALUE FUND II LP. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…